ABEO vs CB · rev $3.5M vs P/E 14, rev $59.40B
Abeona Therapeutics Inc (ABEO) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ABEO currently screens at market cap $301.8M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ABEO and CB stock pages for the full models.
Not investment advice.